New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Kidney Repair Could Be on the Horizon

The discovery could give new hope to dialysis patients by inhibiting a protein that plays a major part in organ damage.

Screen Shot 2022 04 18 At 2 39 45 Pm
Getty Images

In the United States, nearly 800,000 people are living with end-stage renal disease (ESRD). More than two-thirds of these patients are on dialysis, a process that purifies the blood since the kidneys no longer can. However, according to a recent article from The Straits Times, a new discovery aims to take pressure off the organ transplant lists and the need for dialysis by actually repairing damaged kidneys. Researchers from Duke-NUS Medical School, National heart Centre Singapore, and Germany found a way to inhibit a protein that contributes significantly to organ damage, which led to the regeneration of injured kidneys and restoration of renal function.

The treatment targets the cells lining the tubes inside kidneys that return filtered nutrients back into the body and retain urine. Introducing neutralizing antibodies causes the kidney cells to proliferate and regenerate the kidney to reverse damage. It has the possibility to restore other organs as well, including lungs and livers. Tests on mice yielded promising results, and human trials on healthy patients will begin in early 2023. If all goes well, clinical trials should begin in 2024. When commercially available, the team expects the the treatment to be expensive, but cheaper and less taxing than dialysis.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts